表纸
市场调查报告书
商品编码
824084

遗传基因合成的全球市场:成长,趋势,预测(2019~2024年)

Gene Synthesis Market - Growth, Trends, and Forecast (2020 - 2025)

出版日期: | 出版商: Mordor Intelligence Pvt Ltd | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

  • 全貌
  • 简介
  • 目录
简介

全球遗传基因合成市场,预计至2024年将以以17.0%的年复合成长率扩大。基因学和次世代定序领域的研究开发的扩大,对基因学的政府资金援助,对个人化医疗的需求扩大等,支撑这个成长。

本报告提供全球遗传基因合成市场相关调查,汇整市场趋势与各市场区隔趋势,各地区预测,加入此市场的主要企业简介等相关资讯。

第1章 简介

第2章 调查方法

第3章 摘要整理

第4章 市场趋势

  • 市场概要
  • 推动市场的要素
    • 基因学和次世代定序的领域的研究开发扩大
    • 政府对基因学的资金援助
    • 对个人化医疗的需求扩大
  • 阻碍市场的要素
    • 熟练的专家不足
    • 成本高及技术的复杂
  • 波特五力分析

第5章 市场区隔

  • 各手法
    • 寡核苷酸合成
    • 遗传基因集合
  • 各终端用户
    • 学术研究机关
    • 生物医药品厂商
    • CRO
  • 各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 中东、非洲
    • 南美

第6章 竞争趋势

  • 企业简介
    • ATUM (DNA2.0 Inc.)
    • Bio Basic Inc.
    • Beijing SBS Genetech Co. Ltd
    • Eurofins Genomics
    • Genewiz Inc.
    • Genscript Biotech Corp.
    • Merck KGaA
    • OriGene Technologies Inc.
    • Thermo Fisher Scientific Inc. (GeneArt)

第7章 市场机会与未来趋势

目录
Product Code: 64485

Factors that are responsible for the growth of Gene Synthesis market include increasing R&D in the field of genomics and next-generation sequencing, increased government funding toward genomics, and increasing demand for personalized medicine. As personalized medicine aims to provide tailor-made therapies to individual patients, depending on the molecular basis of disease, it has become popular over recent years. Healthcare technology, genomics, connected devices, big data analytics, and artificial intelligence are generating vast amounts of health data and insights. This is enabling healthcare providers to offer better and faster diagnoses, and make more informed treatment decisions. Factors, such as the aging global population and rising prevalence of chronic diseases, are putting unrelenting pressure on the capacity and financial viability of the healthcare systems across the world. Personalized medicine holds the promise of providing better patient care and a high safety margin, while lowering the total healthcare costs. In addition, gene synthesis is also finding its applications in the molecular diagnosis of infectious and genetic diseases. Genetic tests, which can detect genetic variations and predict how a person is likely to respond to certain drugs, are becoming commercially available.

Therefore, increasing focus on personalized medicine and other factors, such as patient-centered approach, are driving the growth of the gene synthesis market.

Key Market Trends

PCR-mediated Assembly is Expected to Grow Rapidly in the Gene Assembly Segment

In the gene synthesis process, the chemical synthesis is typically used to create oligonucleotides of up to 120-150 nucleotide (nt) in length. Therefore, generally, gene assembly techniques are utilized to connect small oligonucleotides with each other, to synthesize the gene of the required length. Over the past three decades, a number of methods have been developed to assemble relatively short synthetic oligonucleotides into longer gene sequences. And the PCR-mediated assembly represents one of the most prominent approaches to mediate assembly of the desired DNA sequence. Pertaining to the broad applications of PCR, such as in molecular diagnostics, forensics, and epidemiology studies, the demand and acceptance of PCR technologies are high, which, in turn, acts as a favorable factor for the development and adoption of PCR-mediated assembly methodologies, by academia and research institutes alike.

North America Dominates the Market and is Expected to do Same during the Forecast Period

Currently, North America dominates the market for gene synthesis, and is expected to continue its stronghold for a few more years. In the North American region, the United States holds the largest market share. The increasing prevalence of genetic and chronic disorders, such as cancer, aging population, increasing demand for targeted and personalized medicine, and favorable government initiatives are the primary factors responsible for the large market.

Competitive Landscape

The gene synthesis market is moderately competitive and consists of several major players. In terms of the market share, few of the major players currently dominate the market. Owing to the increasing number of diseases and rising drug discovery processes, few other smaller players are expected to enter the market. Some of the major players of the market are Merck KGaA, Genscript Biotech Corp., Genewiz Inc., Eurofins Genomics, and Bio Basic Inc., among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing R&D in the Field of Genomics and Next Generation Sequencing
    • 4.2.2 Increased Government Funding toward Genomics
    • 4.2.3 Increasing Demand for Personalized Medicine
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Professionals
    • 4.3.2 High Cost and Complexity of Techniques
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Method
    • 5.1.1 Oligonucleotide Synthesis
      • 5.1.1.1 Solid Phase Phosphoramidite Synthesis
      • 5.1.1.2 Microchip-based Oligonucleotide Synthesis
    • 5.1.2 Gene Assembly
      • 5.1.2.1 Ligation-mediated Assembly
      • 5.1.2.2 PCR-mediated Assembly
  • 5.2 By End User
    • 5.2.1 Academic and Research Institutes
    • 5.2.2 Biopharmaceutical Companies
    • 5.2.3 Contract Research Organizations
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 ATUM (DNA2.0 Inc.)
    • 6.1.2 Bio Basic Inc.
    • 6.1.3 Beijing SBS Genetech Co. Ltd
    • 6.1.4 Eurofins Genomics
    • 6.1.5 Genewiz Inc.
    • 6.1.6 Genscript Biotech Corp.
    • 6.1.7 Merck KGaA
    • 6.1.8 OriGene Technologies Inc.
    • 6.1.9 Thermo Fisher Scientific Inc. (GeneArt)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS